Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siemers

Showing results (331-340 of 443) with videos related to

Pageof 45
Sort By:
The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.
Molecular Biology of the Cell|September 8, 2017
Adhesion to the host cell surface is sufficient to mediate <i>Listeria monocytogenes</i> entry into epithelial cellsFabian E Ortega, Michelle Rengarajan, Natalie Chavez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2023
Expectations and clinical meaningfulness of randomized controlled trialsRonald C Petersen, Paul S Aisen, J Scott Andrews, et al.
Journal of Alzheimer'S Disease : JAD|July 17, 2012
Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementiaPeng Yu, Robert A Dean, Stephen D Hall, et al.
The Journal of Prevention of Alzheimer'S Disease|January 15, 2023
ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aß Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development PlanE Siemers, J Hitchcock, K Sundell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 5, 2015
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patientsEric R Siemers, Karen L Sundell, Christopher Carlson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Suicidal ideation and behavior assessment in dementia studies: An Internet surveyPhillip Chappell, Sarah Dubrava, Michelle Stewart, et al.
The International Journal of Artificial Organs|May 20, 2017
Continuous hemoadsorption with a cytokine adsorber during sepsis - a review of the literatureKhosrow S Houschyar, Malcolm N Pyles, Susanne Rein, et al.
Alzheimer Disease and Associated Disorders|February 24, 2006
The role of biomarkers in clinical trials for Alzheimer diseaseLeon J Thal, Kejal Kantarci, Eric M Reiman, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|June 2, 2018
Electrical injury - a dual center analysis of patient characteristics, therapeutic specifics and outcome predictorsJochen Gille, Thomas Schmidt, Adrian Dragu, et al.
Pageof 45

Showing results (331-340 of 443) with videos related to

Sort By:
Pageof 45
The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.
Molecular Biology of the Cell|September 8, 2017
Adhesion to the host cell surface is sufficient to mediate <i>Listeria monocytogenes</i> entry into epithelial cellsFabian E Ortega, Michelle Rengarajan, Natalie Chavez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2023
Expectations and clinical meaningfulness of randomized controlled trialsRonald C Petersen, Paul S Aisen, J Scott Andrews, et al.
Journal of Alzheimer'S Disease : JAD|July 17, 2012
Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementiaPeng Yu, Robert A Dean, Stephen D Hall, et al.
The Journal of Prevention of Alzheimer'S Disease|January 15, 2023
ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aß Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development PlanE Siemers, J Hitchcock, K Sundell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 5, 2015
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patientsEric R Siemers, Karen L Sundell, Christopher Carlson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Suicidal ideation and behavior assessment in dementia studies: An Internet surveyPhillip Chappell, Sarah Dubrava, Michelle Stewart, et al.
The International Journal of Artificial Organs|May 20, 2017
Continuous hemoadsorption with a cytokine adsorber during sepsis - a review of the literatureKhosrow S Houschyar, Malcolm N Pyles, Susanne Rein, et al.
Alzheimer Disease and Associated Disorders|February 24, 2006
The role of biomarkers in clinical trials for Alzheimer diseaseLeon J Thal, Kejal Kantarci, Eric M Reiman, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|June 2, 2018
Electrical injury - a dual center analysis of patient characteristics, therapeutic specifics and outcome predictorsJochen Gille, Thomas Schmidt, Adrian Dragu, et al.
Pageof 45